Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients
Invasive fungal infections pose a critical threat for children suffering from hematologic malignancies or immunodeficiency disorders.
